Anika Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Anika Therapeutics, Inc. (ANIK) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $6.49 million as of 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-03-03
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6.49M.
- 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6.88M.
- 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $7.95M.
- 2022-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $9.03M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-12-31 | $6.49M 10-K · filed 2026-03-03 |
| 2024-12-31 | $6.88M 10-K · filed 2025-03-17 |
| 2023-12-31 | $7.95M 10-K · filed 2024-03-15 |
| 2022-12-31 | $9.03M 10-K · filed 2023-03-16 |
| 2022-09-30 | $9.42M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $9.64M 10-Q · filed 2022-08-04 |
| 2021-12-31 | $7.17M 10-K · filed 2022-03-11 |
| 2020-12-31 | $7.78M 10-K/A · filed 2021-04-26 |
| 2020-09-30 | $8.10M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $8.40M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $8.68M 10-Q · filed 2020-05-22 |
| 2019-12-31 | $8.79M 10-K · filed 2020-03-06 |
| 2019-09-30 | $9.31M 10-Q · filed 2019-10-28 |
| 2019-06-30 | $9.44M 10-Q · filed 2019-07-26 |
| 2019-03-31 | $9.71M 10-Q · filed 2019-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |